United States · FDA National Drug Code directory
Nilotinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-032_d748f03e-56ba-48e2-ae13-e8e74fac55e7
- Product NDC
- 69097-032
- Form
- CAPSULE
- Composition / generic term
- Nilotinib
- Labeler
- Cipla USA Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250618
- Source listing expiry
- 20261231
Source-listed ingredients
- NILOTINIB — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 CARTON in 1 CARTON (69097-032-74) / 4 BLISTER PACK in 1 CARTON (69097-032-56) / 7 CAPSULE in 1 BLISTER PACK (69097-032-17) · 69097-032-74
- 4 CARTON in 1 CARTON (69097-032-91) / 2 BLISTER PACK in 1 CARTON (69097-032-73) / 14 CAPSULE in 1 BLISTER PACK (69097-032-76) · 69097-032-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →